InvestSMART

BCAL Diagnostics Limited (ASX: BDX) - Announcements

Current share price for BDX : $0.091 0.001 (1.11%)+

ASX company news and announcements for BCAL Diagnostics Limited (BDX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All BCAL Diagnostics Limited (BDX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than BCAL Diagnostics Limited (BDX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for BCAL Diagnostics Limited (BDX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$34 BCAL Presentation Accepted for 2022 ASCO Annual Meeting 1 Jun 2022 8:29AM $0.096 $0.091 fallen by 5.21%
$34 Application for quotation of securities - BDX 3 May 2022 8:11AM $0.105 $0.091 fallen by 13.33%
$34 BCAL to Present at NWR Virtual Investor Conference 2 May 2022 8:22AM $0.105 $0.091 fallen by 13.33%
$34 Quarterly Activities/Appendix 4C Cash Flow Report 28 Apr 2022 8:18AM $0.105 $0.091 fallen by 13.33%
$34 Shareholder Newsletter 24 Mar 2022 11:16AM $0.130 $0.091 fallen by 30%
$34 Change of Director's Interest Notice 2 Mar 2022 6:32PM $0.110 $0.091 fallen by 17.27%
$34 Appendix 4D & Interim Report 18 Feb 2022 8:11AM $0.125 $0.091 fallen by 27.20%
$34 Shares to be released from escrow 14 Feb 2022 9:37AM $0.145 $0.091 fallen by 37.24%
$34 7 February Announcement - Additional Information 8 Feb 2022 2:40PM $0.128 $0.091 fallen by 28.63%
$34 Recent Analysis Significantly Improves Commercial Prospects 7 Feb 2022 8:35AM $0.110 $0.091 fallen by 17.27%
$34 Appendix 4C Revised 4 Feb 2022 3:57PM $0.110 $0.091 fallen by 17.27%
$34 Becoming a substantial holder 31 Jan 2022 4:45PM $0.105 $0.091 fallen by 13.33%
$34 Quarterly Activities/Appendix 4C Cash Flow Report 27 Jan 2022 8:24AM $0.098 $0.091 fallen by 7.14%
$34 Dr John Hurrell Appointed Chief Executive Officer 11 Jan 2022 8:21AM $0.130 $0.091 fallen by 30%
$34 Application for quotation of securities - BDX 29 Dec 2021 3:08PM $0.135 $0.091 fallen by 32.59%
$34 Change In Directors Interest Notice - Correction 13 Dec 2021 6:19PM $0.140 $0.091 fallen by 35%
$34 Directors Change of Interest Notice X 2 13 Dec 2021 9:04AM $0.130 $0.091 fallen by 30%
$34 Results of Meeting 23 Nov 2021 7:26PM $0.150 $0.091 fallen by 39.33%
$34 Results of Meeting 22 Nov 2021 5:43PM $0.155 $0.091 fallen by 41.29%
$34 AGM Presentation 22 Nov 2021 3:58PM $0.153 $0.091 fallen by 40.33%
$34 Addendum to Appendix 4C 8 Nov 2021 9:45AM $0.150 $0.091 fallen by 39.33%
$34 Strong Cohort 4 Testing Data Demonstrates Value of BCAL Test 3 Nov 2021 8:21AM $0.155 $0.091 fallen by 41.29%
$34 Quarterly Activities/Appendix 4C Cash Flow Report 28 Oct 2021 9:18AM $0.160 $0.091 fallen by 43.13%
$34 Ceasing to be a substantial holder 26 Oct 2021 4:52PM $0.160 $0.091 fallen by 43.13%
$34 letter to Shareholders AGM Notice 21 Oct 2021 2:13PM $0.165 $0.091 fallen by 44.85%

226 - 250 of 277 results

Page 10 of 12

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.